EcoDrugPlus

Protein Kinase C Epsilon

Ensembl ID : ENSCHOG00000012392
Gene Symbol: PRKCE
1 Cross references
328 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSCHOG00000001403
Gene Symbol: PRKCH
1 Cross references
241 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSCHOG00000006262
Gene Symbol: PRKCI
1 Cross references
226 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSCHOG00000000062
Gene Symbol: PRKCQ
1 Cross references
204 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSCHOG00000009797
Gene Symbol: PRKD1
1 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSCHOG00000013060
Gene Symbol: PRKD3
1 Cross references
274 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSCHOG00000005823
Gene Symbol: PRKDC
1 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSCHOG00000008813
Gene Symbol: PPP3CA
1 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSCHOG00000010980
Gene Symbol: PTK2
1 Cross references
233 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSCHOG00000001293
Gene Symbol: PTPRB
1 Cross references
268 Possible Orthologues:

Purinergic Receptor P2x 3

Ensembl ID : ENSCHOG00000006480
Gene Symbol: P2RX3
1 Cross references
272 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSCHOG00000000738
Gene Symbol: P2RY12
1 Cross references
182 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).